Selected article for: "incubation period distribution and latent period distribution"
Author: Corey M Peak; Lauren M Childs; Yonatan H Grad; Caroline O Buckee
Title: Containing Emerging Epidemics: a Quantitative Comparison of Quarantine and Symptom Monitoring
  • Document date: 2016_8_31
    • ID: 2j4z5rp8_52
    Snippet: Holding the incubation period distribution constant, we fit an offset for the latent period ( !""#$% ) for several reasons, including consistency with CDC methods for disease characterization (33), the biological expectation of these timings both being linked to pathogen load, and to parsimoniously limit each characteristic to one interpretable parameter. For the duration of infectiousness ( !"# ), we fit the upper bound of a uniform . CC-BY-ND 4.....
    Document: Holding the incubation period distribution constant, we fit an offset for the latent period ( !""#$% ) for several reasons, including consistency with CDC methods for disease characterization (33), the biological expectation of these timings both being linked to pathogen load, and to parsimoniously limit each characteristic to one interpretable parameter. For the duration of infectiousness ( !"# ), we fit the upper bound of a uniform . CC-BY-ND 4.0 International license is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/072652 doi: bioRxiv preprint distribution with a lower bound of 1 day. To allow for variable infectiousness during this duration, we assume a triangular distribution of relative infectiousness ! and fit the time of peak infectiousness ( ! ). A full description of the model parameterization can be found in the S2 Appendix.

    Search related documents:
    Co phrase search for related documents
    • cc ND International license and incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc ND International license and infectiousness duration: 1
    • cc ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc ND International license and interpretable parameter: 1
    • cc ND International license and latent period: 1, 2, 3
    • cc ND International license and model parameterization: 1
    • disease characterization and International license: 1
    • incubation period and infectiousness duration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • incubation period and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • incubation period and latent period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • incubation period and latent period offset: 1
    • incubation period and model parameterization: 1
    • infectiousness duration and International license: 1, 2, 3
    • infectiousness duration and latent period: 1, 2, 3, 4, 5, 6, 7, 8
    • infectiousness duration and latent period offset: 1
    • infectiousness duration and model parameterization: 1
    • International license and latent period: 1, 2, 3
    • International license and low bound: 1
    • International license and model parameterization: 1